India to Italy: Liraglutide Export Trade Route

The India to Italy Liraglutide corridor is one of India's established pharmaceutical export routes, with 13 shipments documented worth a combined $9.2K USD. The route is dominated by REGALIA LIFE SCIENCE PRIVATE LIMITED, which alone accounts for roughly 88% of all export value, reflecting the consolidated nature of India's liraglutide manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $707 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with liraglutide's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 33.2%, placing it at rank #7 among India's top liraglutide export destinations globally.

On the import side, key buyers of Indian liraglutide in Italy include PURCHASE MANAGER, NUOVA OMPI S.R.L UNIPERSONALE, MERIEUX NUTRISCIENCES. PURCHASE MANAGER is the single largest importer with 6 shipments valued at $8.1K USD.

India's liraglutide exports to Italy are driven primarily by a handful of large-scale manufacturers. REGALIA LIFE SCIENCE PRIVATE LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Italy benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — REGALIA LIFE SCIENCE PRIVATE LIMITED, ONESOURCE SPECIALTY PHARMA LIMITED — together account for 100% of total trade value on this route. The average shipment value of $707 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless pharmaceutical products for human use liraglutide solution for injection in a prefilled pen for s.c use and harmless pharmaceutical products for human use liraglutide solution for injection in a prefilled pen for s.c, suggesting that buyers in Italy tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, PURCHASE MANAGER is the largest importer with 6 shipments worth $8.1K USD — representing 88% of all liraglutide imports from India on this route.